AIDS drugs maker provides state-of-art HIV drugs to Africa for $75 a year

Makers of generic AIDS drugs will start churning out millions of pills for Africa containing a state-of-the-art medicine widely used in rich countries, after securing a multi-million dollar guarantee that caps prices at just $75 per patient a year. Global health experts hope the deal will help address two looming problems in the HIV epidemic […]

Read More

Shareholders urge GSK to employ strategies to grow profits

Shareholders of GlaxoSmithKline Consumer Nigeria Plc (GSK), has urged the management of the company to employ strategies that will help drive its business on the path of profitability. The shareholders who spoke during the company’s 46th annual general meeting in Lagos argued that considering the challenging operating environment, the management of GSK should ensure it […]

Read More